Opinion | COVID Convalescent Plasma Finds a Therapeutic Role
Growing evidence shows benefits in the immunocompromised
Related Articles
Opinion | The Hidden Cost of Poor Hospital Waste Management
Proper disposal of OR trash could save the healthcare system millions — and help the environment
Brain Injury More Severe From Falls at U.S.-Mexico Border Wall
People with border wall falls were less likely to receive follow-up care
New Document Guides Clinical Decision-Making on Atopic Dermatitis Treatment
A recent review has found that high-dose upadacitinib is among the most effective therapies for addressing multiple outcomes in moderate-to-severe atopic dermatitis (AD), but is…
New Consensus Recs for Oral Immunotherapy in Food Allergies
Allergist Zahida Maskatia, MD, shares how the guidelines will change practice
COVID-19 vaccination and breakthrough infections in patients with cancer
Vaccination is an important preventive health measure to protect against symptomatic and severe COVID-19. Impaired immunity secondary to an underlying malignancy or recent receipt of…
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19
Background Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a…
COVID-19 and Cancer—A Review of the Registry-Based Pandemic Response
This review describes the registry efforts made during the COVID-19 pandemic with the aim of investigating and sharing information about the history, risk factors, and…
The impact of cancer metastases on COVID‐19 outcomes: A COVID‐19 and Cancer Consortium registry‐based retrospective cohort study
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study
AbstractBackground. The frequency of coinfections and their association with outcomes have not been adequately studied among patients with cancer and coronaviru
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Patients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of…